Finance

Lists
ROVI:BME
Laboratorios Farmaceuticos ROVI SA
58,80 €
+1,29%
(+0,75) 1D
12 ოქტ, 16:27:59 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ROVI...
Open
58,90 €
High
58,95 €
Low
58,40 €
Mkt. cap
3,01 მლრდ.
Avg. vol.
83,64 ათ.
Volume
26,10 ათ.
Dividend
1,63%
Quarterly dividend
0,24 €
Ex-dividend date
13 ივლ. 2026
P/E ratio
16,28
52-wk high
86,70 €
52-wk low
53,10 €
EPS
3,61 €
Shares outstanding
51,24 მლნ.
No. of employees
2 ათ.
Open
58,90 €
High
58,95 €
Low
58,40 €
Mkt. cap
3,01 მლრდ.
Avg. vol.
83,64 ათ.
Volume
26,10 ათ.
Dividend
1,63%
Quarterly dividend
0,24 €
Ex-dividend date
13 ივლ. 2026
P/E ratio
16,28
52-wk high
86,70 €
52-wk low
53,10 €
EPS
3,61 €
Shares outstanding
51,24 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
3 საათის წინ
Rovi stock trades at EUR 58.65 with a P/ E ratio of 16.2
ad-hoc-news.de
ad-hoc-news.de
·
6 საათის წინ
Rovi stock sits 32.47 percent below its EUR 86.70 high
ad-hoc-news.de
ad-hoc-news.de
·
8 საათის წინ
Rovi stock pre-market at EUR 58.28
Profile
Laboratorios Farmaceuticos Rovi SA is a Spanish pharmaceutical company. The company is a member of the IBEX 35 stock market index. Wikipedia
About Laboratorios Farmaceuticos ROVI SA
CEO-
Employees2,47 ათ.
Founded1946
Headquarters-
SectorPharmaceutical industry
Websiterovi.es
Last report
23 ივლ. 2026
Fiscal period
Q2 2026
1,46 € / -
0,00%miss
Revenue / Est. (EUR)
344,16 მლნ. / 179,82 მლნ.
+91,39%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
210,47 მლნ.
218,42 მლნ.
152,49 მლნ.
191,67 მლნ.
Cost of goods sold
62,66 მლნ.
90,33 მლნ.
59,61 მლნ.
60,04 მლნ.
Cost of revenue
62,66 მლნ.
90,33 მლნ.
59,61 მლნ.
60,04 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,66 მლნ.
55,40 მლნ.
38,04 მლნ.
47,22 მლნ.
Operating expense
79,83 მლნ.
73,16 მლნ.
83,00 მლნ.
113,58 მლნ.
Total operating expenses
142,49 მლნ.
163,49 მლნ.
142,61 მლნ.
173,62 მლნ.
Operating income
67,98 მლნ.
54,93 მლნ.
9,89 მლნ.
18,05 მლნ.
Other non operating income
8,35 მლნ.
3,80 მლნ.
2,32 მლნ.
10,64 მლნ.
EBT including unusual items
75,70 მლნ.
57,94 მლნ.
12,29 მლნ.
89,28 მლნ.
EBT excluding unusual items
75,70 მლნ.
57,94 მლნ.
12,29 მლნ.
26,93 მლნ.
Income tax expense
17,68 მლნ.
15,29 მლნ.
2,84 მლნ.
14,35 მლნ.
Effective tax rate
23,36%
26,39%
23,11%
16,07%
Other operating expenses
37,70 მლნ.
9,61 მლნ.
36,79 მლნ.
56,55 მლნ.
Net income
58,03 მლნ.
42,68 მლნ.
9,48 მლნ.
75,00 მლნ.
Net profit margin
27,57%
19,54%
6,22%
39,13%
Earnings per share
-
-
-
-
Interest and investment income
86,00 ათ.
-
403,00 ათ.
474,00 ათ.
Interest expense
-757,00 ათ.
-767,00 ათ.
-782,00 ათ.
-1,97 მლნ.
Net interest expenses
-671,00 ათ.
-767,00 ათ.
-379,00 ათ.
-1,50 მლნ.
Depreciation and amortization charges
7,47 მლნ.
8,16 მლნ.
8,17 მლნ.
9,81 მლნ.
EBITDA
79,21 მლნ.
55,10 მლნ.
18,05 მლნ.
23,60 მლნ.
Gain or loss from assets sale
-
14,00 ათ.
1,77 მლნ.
-2,00 ათ.
AI content may include mistakes. Learn more
Google აპები